5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[[4-[[(2-amino-1-carboxy-2-oxoethylidene)-1,3-dithietan-2-yl]carbonyl]amino]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,disodium salt,[6R-(6a,7a)]-.
(6R,7S)-4-[[2-Carboxy-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-7-yl]carbamoyl]-1,3-dithietane-D2,a-malonamic acid,disodium salt.
(6R,7S)-7-[4-(Carbamoylcarboxymethylene)-1,3-dithietane-2-carboxamido]-7-methoxy-3-[[(1-methyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,disodium salt
[74356-00-6].
Packaging and storage
Preserve in tight containers.
Labeling
Where it is intended for use in preparing injectable dosage forms,the label states that it is sterile or must be subjected to further processing during the preparation of injectable dosage forms.
Identification
A:
The retention time of the major peak in the chromatogram of the
Assay preparationcorresponds to that of the
Standard preparationobtained as directed in the
Assay.
B:
It responds to the tests for Sodium á191ñ.
pHá791ñ:
between 4.0and 6.5,in a solution (1in 10).
Water,Method ICá921ñ:
not more than 1.5%.
Assay
[NOTEProtect the
Standard preparation,the
Resolution solution,and the
Assay preparations from light,and use within 2hours.
]
Mobile phase,Standard preparation,Resolution solution,and Chromatographic system
Proceed as directed in the
Assayunder
Cefotetan.
Assay preparation
Transfer about 40mg of Cefotetan Disodium,accurately weighed,to a 200-mLvolumetric flask,add 10mLof methanol,swirl for several minutes,add 10mLof acetonitrile,and swirl until dissolved.Dilute with water to volume,and mix.
Procedure
Proceed as directed for
Procedurein the
Assayunder
Cefotetan.Calculate the quantity,in µg,of cefotetan (C
17H
17N
7O
8S
4)per mg in the portion of Cefotetan Disodium taken by the formula:
200(CP/M)(rU/rS),
in which the terms are as defined therein.